From: In-silico interaction-resolution pathway activity quantification and application to identifying cancer subtypes
Group I
Group II
Number of patients
90
85
Stage I
18 (p = 0.0362)
7 (p = 0.9764)
Stage II
11 (p = 0.9779)
24 (p = 0.0049)
Stage III
16 (p = 0.4976)
18 (p = 0.1623)
Stage IV
2 (p = 0.3258)
2 (p = 0.2889)